A retrospective analysis of the safety and efficacy of apixaban use after lung transplant.

Autor: Reininger KA; Department of Pharmacy, Hennepin County Medical Center, Minneapolis, MN, USA., Sam T; Department of Pharmacy, Baylor University Medical Center, Dallas, TX, USA., Patel RS; Department of Pharmacy, Baylor University Medical Center, Dallas, TX, USA., Grazia TJ; Center for Advanced Heart and Lung Disease, Baylor University Medical Center, Dallas, TX, USA., Naik CA; Center for Advanced Heart and Lung Disease, Baylor University Medical Center, Dallas, TX, USA., Ausloos KA; Center for Advanced Heart and Lung Disease, Baylor University Medical Center, Dallas, TX, USA., Rosenblatt RL; Center for Advanced Heart and Lung Disease, Baylor University Medical Center, Dallas, TX, USA., Lam ILL; Department of Pharmacy, Sharp Memorial Hospital, San Diego, CA, USA.

Publikováno v: Clinical transplantation [Clin Transplant] 2021 Jul; Vol. 35 (7), pp. e14327. Date of Electronic Publication: 2021 May 03.